Profile photo of Girish K. Malhotra

Girish K. Malhotra

Consultant improving Profitability through simplicity Fine/Specialty Chemicals, Active Pharma Ingredients, Coatings, Resins, Latex polymers, Flavors & Fragrances. Process Development Commercialization Optimization Profitability improvement Turn Around Manufacturing Technology Innovation
Certificate # 861
EPCOT International
29150 Bryce Road
Pepper Pike, OH 44124-5701
Phone #: (216) 292-0626
Cell #: 216-288-6489
Fax #: 216-292-0626

Fine/Specialty Chemicals, Active Pharma Ingredients, Coatings, Resins, Latex polymers, Flavors & Fragrances Specializes in profitability improvement Quality Improvement EPA liaison and compliance, Effluent reduction & pollution prevention Cost reduction Improve asset utilization, technology development, assessment and evaluation, technology review, due diligence, process design, strategic partnership and alliances, technology transfer intellectual property,

Publications & Presentations

  1. US Patent # 4,269,987 issued on May 26, 1981
  2. Numerous technology innovations disclosed and not filed to protect process inventions.
  3. Malhotra, Girish:: Continuous vs. Batch Manufacturing, Paint and Coatings Industry, February 1999, Pages 100-103
  4. Malhotra, Girish: ViewPoint: The Coating Industry’s Challenge for the New Millennium, Modern Paint & Coatings, October 1999, Page 60
  5. Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; The Color of   Money: New technology helps improve coatings production efficiency and profitability, Modern Paint & Coatings, Feb. 2001, Page 22-24.
  6. Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; In-line measurement and correction of Color and physical properties; 7th Nürnberg Coatings Conference, Nürnberg April 7-8, 2003
  7. Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; In-line measurement and correction of Color and physical properties; Symposium on Color and Appearance Instrumentation, April 15-16, 2003, Chicago, IL
  8. Malhotra, Girish: Process Puzzler: Maintaining Pump Prime: De-gas the ammonia; Chemical Processing, May 2004, pg 38
  9. Malhotra, Girish: Process Puzzler: Take out Torque Slowly add fine powder: Chemical Processing, October 2004, pg 50
  10. Malhotra, Girish; Peixoto, Carlos A; Schotgues, Eduardo; Pfeil, Paulo R; New Paradigm For Coating Manufacturing Processes; International Coatings Exposition October 25-29, 2004, Chicago, IL
  11. Malhotra, Girish: Coating manufacturing processes: Yesterday, today and tomorrow, Jan 5, 2005
  12. Malhotra, Girish: Dispersion Equipment – an overview; March 2, 2005
  13. Malhotra, Girish: Multicell Technology; Annual R&D Council and Operations Management Meeting for a major coating company; March 2005
  14. Malhotra, Girish: Batch or a Continuous Process: A Choice; Pharmaceutical Processing, March 2005, Page 16
  15. Malhotra, Girish: Process Puzzler: Stop Solvent losses; Chemical Processing, March 2005, Page 45
  16. Malhotra, Girish: Process Puzzler: Choose a pump wisely: Chemical Processing
  17. Malhotra, Girish: Volatile Organic Compounds (VOC) regulations and Coating Industry, May 2005
  18. Malhotra, Girish: Process Puzzler: Know when the end is near: Chemical Processing, June 2005, Page 39
  19. Chemical Week India Looks to Ethical Drugs, June 15, 2005, Page 27    H
  20. Malhotra, Girish, Less is More in API Process Development: Pharmaceutical Manufacturing, July/August 2005, Pages 50-51
  21. Malhotra, Girish: Process Puzzler: Vanquish material variations: Chemical Processing, July 2005, Page 45
  22. Malhotra, Girish: Process Puzzler: Remove the fatty oil first: Chemical Processing, August 2005, Page 54
  23. Malhotra, Girish ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE, October 26, 2005   H
  24. Malhotra, Girish: API Manufacture-Simplification and PAT:  Pharmaceutical Processing, November 2005, Pages 24-27 H
  25. Malhotra, Girish: Process Puzzler: Prevent heat-exchanger plugging: Recycle concentrated solution: Chemical Processing, November 2005, Page 52
  26. Malhotra, Girish: Simplification is Profitability: Pharmaceutical Technology, December 2005, Pages 14-16
  27. Malhotra, Girish: Pharma’s Changing workforce, Pharmaceutical Manufacturing, November/December 2005, Page 11
  28. Malhotra, Girish: Making sense of temperature sensing: Poor Mixing? Chemical Processing January 2006
  29. Malhotra, Girish: Indian Firms Tear Into Overseas API Markets, Chemical Week February 15, 2006, Pg 27- 36.
  30. Malhotra, Girish: Engineering, innovation, national well being. Chemical Engineering March 2006 Page 8
  31. Malhotra, Girish: Fine Chemical Failures. Chemical Week, May 17, 2006, Page 5
  32. Malhotra, Girish: Pharma Intermediates: M&A Frenzy Takes Hold, Chemical Week May 31, 2006, Page 33
  33. Malhotra, Girish: Process Puzzler: Boost the reliability of a solvent supply pump- Use eccentric reducers: Chemical Processing, May 2006
  34. Malhotra, Girish: Process Puzzler: Uncovering cause of solid build-up- Look at the material balance: Chemical Processing, September 2006
  35. Malhotra, Girish: Indian Firm First to Gain FDA Approval for Pharma Formulation Intermediate, Chemical Week, September 20, 2006, Page 52
  36. Malhotra, Girish: Process Puzzler: Automation – a boost to morale: Chemical Processing, November 2006, Page 50
  37. Malhotra, Girish: QBD: First Things First, Pharmaceutical Manufacturing, November/ December 2006, Page 9
  38. Malhotra, Girish: Process Puzzler: Sticky Valve-Focus on heat tracing failure: Chemical Processing, January 2007, Page 52
  39. Chemical Week: Pharma Manufacturers Chase Greener, Cost-Efficient Chemistries, February 7, 2007, Page 21, Chemical WeekH
  40. Malhotra, Girish: QBD: Myth or Reality? Pharmaceutical ProcessingH, February 2007, Pages 10-16
  41. Malhotra, Girish: Process Puzzler: Quick fix needed! Eventually, do a redesign Chemical Processing, May 2007, Page 42
  42. Malhotra, Girish: Can Pharma Learn From the Unfolding Gluten Contamination Story? Pharmaceutical Manufacturing, May 3, 2007
  43. Malhotra, Girish: Big Pharma and Lessons From Detroit’s Big Three: Focus on API Manufacturing, Or Lose Your Edge to Offshore Generics, Pharmaceutical Manufacturing, May 16, 2007
  44. Malhotra, Girish: Continuous Processes Maintain Profitability, Drug Discovery and Development, June 2007, Pages 30-31
  45. Malhotra, Girish: Big Pharma: Who’s Your Role Model, Toyota or Edsel? Pharmaceutical Manufacturing, June 2007, Page 40
  46. Malhotra, Girish: Change is needed, GLG Group Analysis, July 16, 2007
  47. Malhotra, Girish: Can Indian Pharmaceutical companies be a threat? GLG Analysis July 27, 2007
  48. Malhotra, Girish: ICI a British Gem is sold GLG Group Analysis August 6, 2007
  49. Malhotra, Girish: Concerns over Akzo buying ICI GLG Group Analysis August 20, 2007
  50. Malhotra, Girish: Is IT a Catalyst for India’s Drug Industry Growth? Pharmaceutical Manufacturing, October 11, 2007
  51. Chemical Week: Green Chemistry October 24, 2007 pg.23-26 Chemical Week
  52. Malhotra, Girish: Pharmaceuticals, Their Manufacturing Methods, Ecotoxicology, and Human Life Relationship, Pharmaceutical Processing, November 2007 Pg 18-23
  53. Malhotra, Girish Personal Dose: A New Direction and Profit, Drug Discovery and Development, December 1, 2007
  54. Chemical Week: Backlash in the Cards from Indian Plant Effluent Study? December 5, 2007 Page 31 Chemical Week
  55. Malhotra, Girish: Dow potential acquisition GLG Group Analysis December 17, 2007
  56. Malhotra, Girish: New approach to develop drugs GLG Group Analysis December 20, 2007
  57. Malhotra, Girish: Conversation of ABC, Dec. 2007 Published by EPCOT International
  58. Malhotra, Girish: Implementing QbD: A Step-by-Step Approach,Pharmaceutical Processing, February 2008 Pg 16-18
  59. Malhotra, Girish: Is close good enough-Heparin Fiasco, GLG Group Analysis, March 5, 2008
  60. Malhotra, Girish: A Modest Proposal for High Drug Costs: Let Them Drink Tap Water, March 18, 2008
  61. Malhotra, Girish: Process Puzzler: Clarify a clogged caustic conundrum – Try Recirculation: Chemical Processing March 2008 pg 41-42
  62. Malhotra, Girish: Process Puzzler: Succeed through thick and thin – Maintain the temperature: Chemical Processing April 2008 pg 45-47
  63. Malhotra, Girish: Suzlon is having Teething Problem, GLG Group Analysis, April 22, 2008
  64. Malhotra, Girish: Paint Cost can be reduced by manufacturing technology innovation, GLG Group Analysis April 23, 2008
  65. Malhotra, Girish: Pharmaceutical Manufacturing: Is it the antithesis of Creative Destruction? Pharmaceutical Manufacturing, July 2008
  66. Malhotra, Girish: Opportunities for Private Equity firms in India GLG Group Analysis, July 4, 2008
  67. Malhotra, Girish: Opportunities for the Pharmaceuticals to improve their manufacturing technology, GLG Group Analysis, July 22, 2008
  68. Malhotra, Girish: Pharmaceutical business strategy, GLG Group Analysis, August 7, 2008
  69. Pharmaceutical Manufacturing:As Ranbaxy’s World Turns, So Does Generics Model July/August 2008 pg 12-14
  70. Malhotra, Girish: Pharmaceutical companies and their effort to improve profits, GLG Group Analysis, September 11, 2008
  71. Malhotra, Girish: Ranbaxy citations can be an opportunity, GLG Group Analysis, September 18, 2008
  72. Malhotra, Girish: Pharma Convergence: Challenges in Drug Development and Manufacturing Methods, CHEManager Europe 10/2008, September 18, 2008, pg 26
  73. Malhotra, Girish: API Manufacturing: A Road Map for Green Chemistry and Processes: October 14, 2008
  74. Malhotra, Girish: Is Pharma Consolidation on Horizon, GLG Group Analysis, October 28, 2008
  75. Malhotra, Girish: Process Puzzler: Quell a quality control confrontation- Improve the Design: Chemical Processing November 2008 pg 40-42
  76. Malhotra, Girish: APIs Simplicity by Design. A Low-tech Approach for Quality and Profitability, Mastering Process Chemistry, Philadelphia, November 17-19, 2008
  77. Malhotra, Girish: Is “Creative Destruction” the way to go for the Pharmaceuticals? GLG Group Analysis, December 10, 2008
  78. Malhotra, Girish: Process Puzzler: Get out of the Soup, Chemical Processing, December 2008 pg 28
  79. Malhotra, Girish: Forget Bail Out or Hand Out – the Answer is Innovation and Conservation January 9, 2009 Chemical Week, Profitability through Simplicity
  80. Malhotra, Girish: ISP: A Hidden ‘Diamond in the Rough’ January 13, 2009 Chemical Week, Profitability through Simplicity
  81. Malhotra, Girish: Pfizer/Wyeth and GSK/UCB GLG Group Analysis January 26, 2009
  82. Malhotra, Girish: Commoditization of Drugs February 4, 2009 Chemical Week, Profitability through Simplicity
  83. Malhotra, Girish: Why Have the Fine and Specialty Chemical Sectors Been Moving from Developed Countries? February 9, 2009 Chemical Week, Profitability through Simplicity
  84. Malhotra, Girish: Dow and ROH GLG Group Analysis February 9, 2009
  85. Malhotra, Girish: Alphabet Shuffle: Moving From QbA to QbD – An Example of Continuous Processing, Pharmaceutical Processing, February 2009 pg 12-13
  86. Malhotra, Girish: A Fine Chemical Version of Chernobyl? February 26, 2009 Chemical Week, Profitability through Simplicity
  87. Malhotra, Girish: Pfizer, Generics and Commoditization GLG Group Analysis March 3, 2009
  88. Malhotra, Girish: Rx for Pharma, Chemical Engineering Progress, March 2009, Vol. 105, No. 3 Pg. 34-38
  89. Malhotra, Girish: Global Fine/Specialty Chemical Industry and its Challenges, March 5, 2009, Profitability through Simplicity
  90. Malhotra, Girish: The Challenge for Fine and Specialty Chemical Firms, March 19, 2009 Chemical Week,
  91. Malhotra, Girish: Pharmaceuticals and Return on Investment (ROI), March 26, 2009, Chemical Week, Profitability through Simplicity
  92. Malhotra, Girish: The Nano: The New iPod of the Manufacturing Industry? March 27, 2009 Chemical Week, Profitability through Simplicity
  93. Malhotra, Girish: Pharmaceuticals in Water, April 24, 2009 Profitability through Simplicity
  94. Malhotra, Girish: The Art of API Process Simplification and Scale-Up leading to QBD, Quality by Design Conference, International Pharmaceutical Academy, Toronto, April 27, 2009
  95. Malhotra, Girish Process Puzzler: Kayo a Cascade Control Complication Chemical Processing May 2009 Pg. 43
  96. Malhotra, Girish: Process of Continuous Improvement and Pharmaceuticals, June 1, 2009 GLG Group Analysis Profitability through Simplicity
  97. Malhotra, Girish: What is Holding Back Quality by Design? June 15, 2009 Chemical Week, Profitability through Simplicity
  98. Malhotra, Girish: Recycling Coatings: An Environmental and Business Opportunity, July 8, 2009 Chemical Week, Profitability through Simplicity
  99. Malhotra, Girish: Hesitation In The Drive To A Continuous Pharmaceutical Manufacturing Process: Real or Imaginary? Pharmaceutical Processing, July 2009 pg-12-15
  100. Malhotra, Girish: Climate Change and its Impact on Industrial Production, August 3, 2009 Chemical Week, GLG Group Analysis, Chemical Processing, Profitability through Simplicity
  101. Malhotra, Girish: Chemical Engineering: Understanding the Curriculum for Quality Manufacturing, August 5, 2009 Chemical Week, Chemical Processing, Profitability through Simplicity
  102. Malhotra, Girish: A Pharmaceutical Challenge for Technocrats, August 21, 2009, Chemical Week, Chemical Processing, Profitability through Simplicity
  103. Malhotra, Girish: Photographs, World Photographers Organization, Volume 1, August 2009 pages 6, 13, 14, 15
  104. Malhotra, Girish: Fine Chemicals: Quality Manufacturing and Technology Innovation in Pharmaceuticals, September 25, 2009, Chemical Week, Profitability through Simplicity
  105. Chemical Week, Cost Cutting Becomes the Pharma Industry’s Mantra Chemical Week, October 5, 2009 pg 24-28
  106. Malhotra, Girish: Understanding QbD Requires Basic Fundamentals October 13, 2009
  107. Malhotra, Girish: Photographs, World Photographers Organization, Volume 2, October 2009 page 9
  108. Malhotra, Girish: QBA and Elements of QBD, Quality by Design, Challenges of implementing QbD / PAT in the development of rugged and robust formulations, processes, and Approvals October 19-20, 2009, Somerset, NJ
  109. Malhotra, Girish: Exploitation of QBA Elements for a Batch/ Continuous Process, Quality by Design, Challenges of implementing QbD / PAT in the development of rugged and robust formulations, processes, and Approvals October 19-20, 2009,Somerset, NJ
  110. Malhotra, Girish: An Interpretation of U.S. FDA Guidance for Pharma Manufacture, October 19, 2009 Chemical Week, Profitability through Simplicity
  111. Malhotra, Girish: Review of Continuous Process for Modafinil, Continuous Processing in the Chemical and Pharmaceutical Industry II, 2009 AIChE Annual Meeting, November 10, 2009,Nashville, TN.
  112. Malhotra, Girish: Analysis of API (Omeprazole): My perspective, Poster Session: Pharmaceutical Engineering, 2009 AIChE Annual Meeting, November 11, 2009, Nashville, TN.
  113. Malhotra, Girish: What is Jugaad – a New Management Fad from India? December 10, 2009 Chemical Week, Chemical Processing, Profitability through Simplicity
  114. World Images Today, World Photographers Organization, December 2009, pg 14, 19-21
  115. Malhotra, Girish: A Radical Approach to Fine/Specialty API Manufacturing Chemical Week, Profitability Through Simplicity January 20, 2010
  116. Malhotra, Girish: Pharmexcil to invite drug regulators from Africa for brand buildup GLG Group Analysis January 28, 2010
  117. Malhotra, Girish: HIV Drug Availability and Potential Manufacturing Opportunities, Chemical Week, Profitability Through Simplicity, February 2, 2010
  118. Malhotra, Girish: World Images Today February 2010, pg 55
  119. Malhotra, Girish: Pharmaceutical Costs, Technology Innovation, Opportunities and Reality, Pharmaceutical Processing February 2010 pgs 20-24
  120. Green Chemistry: Lighting Up New Pharma Pathways, Chemical Week March 15, 2010, pgs 21-23
  121. Malhotra, Girish: Relationship between Big Pharmaceuticals and the Indian Pharmaceuticals, GLG Group Analysis March 15, 2010
  122. Malhotra, Girish: Alternate Interpretation of Pharmaceutical TLAs: Three-letter Acronyms Chemical Week, Profitability through Simplicity, Pharmaceutical Processing, March 16, 2010
  123. Malhotra, Girish: Sanofi-Aventis Expansion in India, GLG Analysis, March 23, 2010
  124. Malhotra, Girish: Process Centricity is the Key to Quality by Design, Pharmaceutical Processing, Chemical Week, Profitability through Simplicity April 6, 2010
  125. Malhotra, Girish: Webinar: Simplifying Coating Formulations for Easier Scale-up Webinar, April 27, 2010
  126. Malhotra, Girish: Microscopic Examination of Indian Pharmaceutical Acquisitions by Multinational Companies, Profitability through Simplicity, Chemical Week, GLG Analysis, May 25, 2010
  127. Malhotra, Girish: You’re the CEO: Can You Justify the Costs of These QbD Projects? June 4, 2010
  128. Malhotra, Girish: Pharmaceutical Reverse Payments and Lower Drug Costs: An Interesting Dilemma, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, July 21, 2010
  129. Malhotra, Girish: The Path Towards Continuous Processing, Pharmaceutical Processing, August 2010, pgs 16-20
  130. Malhotra, Girish: Square Plug In A Round Hole: Does this Scenario Exist in Pharmaceutical? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, August 17, 2010
  131. Malhotra, Girish: How Do We Justify Investments in QbD, August 26, 2010,
  132. Malhotra, Girish: The Importance of Fundamentals, Pharmaceutical Processing, Profitability through Simplicity, Chemical Week, August 31, 2010
  133. Malhotra, Girish: Are The Rules A Constraint to Innovation, Competition and A Cause of Adulterated Product? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, October 1, 2010 
  134. Chemical Week: Pharmaceuticals Counterfeiting Drives Change, Chemical Week, September 27/October 4, 2010 pgs 48-50
  135. Malhotra, Girish: QbA–> QbD Imagination and Creativity Challenge, 5th International Conference and Exhibition, Process Analytical Technologies in Organic Process R&D, November 2, 2010, Clearwater, Florida
  136. Malhotra, Girish: Pharmaceutical Companies Can innovate If They Want to, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, October 15, 2010
  137. Malhotra, Girish: Comments on PAT Article, Chemical Engineering, pg 6, October 2010
  138. Malhotra, Girish: Process Puzzler: Deal with a Decanter that C’ant, Chemical Processing, November 2010
  139. Malhotra, Girish: Constructive Destruction in Pharmaceutical Industry, GLG Group Analysis, December 13, 2010
  140. Malhotra, Girish: Mr. Claus, Tear Down These Walls!, December 16, 2010, Pharmaceutical Manufacturing Page 10, January 2011
  141. Malhotra, Girish: Chemical Process Simplification: Improving Productivity and Sustainability, ISBN: 978-0-470-48754-9, Hardcover, 282 pages, January 2011, John Wiley & Sons Inc.
  142. Malhotra, Girish: Inefficiency in Fine Chemicals Manufacture Set to Grow, Chemical Week, February 1, 2011
  143. Malhotra, Girish: Are Patents a Double-Edged Sword? Perspective Matters, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week February 8, 2011
  144. Malhotra, Girish: Chapter “Simplified Process Development and Commercialization” in Quality by Design: From Theory to Practice co-published by Parental Drug Association and DHI Publishing© 2011 February 2011 available at
  145. Malhotra, Girish:Strategies to Enhance API Manufacturing: Identifying inefficiencies and optimizing development through quality by design, Business Insights, London, UK March 2011
  146. Malhotra, Girish: QbA-> QbD: An imagination and creativity challenge, Chemica OGGI/ Chemistry TODAY March/April 2011, Vol. 29 n.2, pg 42-44.
  147. Malhotra, Girish: P&G and Teva is a win-win and Herculean Challenge for Many, GLG Group Analysis, March 26, 2011
  148. Malhotra, Girish: Pharmaceutical Consolidation in the Developed Countries, GLG Group Analysis, March 31, 2011
  149. Malhotra, Girish: Information Challenges for Product, Process Development and Process Design: A Reality Check, Chemical Week, Profitability through Simplicity, Chemical Processing, Pharmaceutical Processing, April 11, 2011
  150. Malhotra, Girish: Opportunities for the Indian Generic Pharmaceuticals, GLG Group Analysis, April 13, 2011
  151. Malhotra, Girish: Pharmaceuticals start their drive to Consolidation, GLG Group Analysis, May 2, 2011
  152. Malhotra, Girish: Who or What killed QbD? And is there hope for resuscitation? Pharmaceutical Processing, May 2011, pg 10-14
  153. Malhotra, Girish: Drug Prices: Food vs. Medicine – A Difficult Choice for Some, Pharmaceutical Processing, Profitability Through Simplicity, Chemical Week, June 17, 2011
  154. Malhotra, Girish: Sun Pharmaceuticals Industries could show Pharma’s new course, GLG Group Analysis, July 5, 2011
  155. Malhotra, Girish: Pharmaceutical Quality: Is it a Company or Regulatory Responsibility? August 1, 2011, Profitability Through Simplicity, Pharmaceutical Processing, Chemical Week
  156. Malhotra, Girish: Big Pharma’s (Pfizer) First BIG Volley Against Generics, GLG Group Analysis, August 4, 2011
  157. Malhotra, Girish: Generic Drug Fees: A Fantastic Opportunity, August 17, 2011, Profitability Through Simplicity, Pharmaceutical Processing, Chemical Week
  158. Malhotra, Girish: Drug Shortages: Causes and Cures, October 13, 2011
    Profitability Through Simplicity, Pharmaceutical Processing, Chemical Week
  159. Malhotra, Girish: Does the Pharmaceutical Industry Need a Steve Jobs? November  9, 2011 Profitability through Simplicity, Pharmaceutical Processing, Chemical Week
  160. Malhotra, Girish: Drugs for Infectious Diseases, Funding and Opportunity, December 11, 2011, Profitability Through Simplicity, Chemical Week, Pharmaceutical Processing
  161. Malhotra, Girish: Manufacturing can address the global disease crisis, G+
    December 19, 2011
  162. Pharmaceuticals: Asian Contract Manufacturers Pose Challenge to Western Firms, Chemical Week, pgs 21-26, Feb6/13, 2012,
  163. Malhotra, Girish: Neglected Tropical Disease Drugs: What are they Telling US About Innovation? March 7, 2012 Profitability through Simplicity, Pharmaceutical Processing, Chemical Week
  164. Malhotra, Girish:Focus on Physical Properties To Improve Processes: Chemical Engineering, Vol. 119 No. 4 April 2012, pgs 63-66
  165. Malhotra, Girish:Can the Combination of Creative Destruction and “Steve Jobs Traits” Lead to a Pharma QbD Spring? April 16, 2012, Profitability through Simplicity, Pharmaceutical Processing, Chemical Week
  166. Malhotra, Girish: A Guide to QbD for APIs, Pharmaceutical Processing, Volume 27, No. 4 May 2012, pg 46-49, Pharma Times November 2012 pg 45-47
  167. Malhotra, Girish: Financial Justification for QbD and Cost of Regulation Compliance Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, May 22, 2012
  168. Malhotra, Girish: Is the New Terminology Going to Make the Pharmaceutical Processes Environmentally Friendly and Economic? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week June 4, 2012
  169. Malhotra, Girish: Is Continuous Processing in Pharma’s Future? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, July  24, 2012
  170. Malhotra, Girish: Are the Savings of $120-$150 Billion Worth Having? Profitability through Simplicity, Pharmaceutical Processing, Chemical Week, August 30, 2012
  171. Malhotra, Girish: Patents: Should We Change Intellectual Property Model/Strategies? Profitability through Simplicity, Chemical Week, Pharmaceutical Processing, October 5, 2012
  172. Malhotra, Girish:Improving Global Affordability of HIV/AIDS Drugs Through Technology Innovation Profitability through Simplicity, Pharmaceutical Processing, Chemical Week October 19, 2012
  173. Malhotra, Girish: Government of India’s Brand vs. Generics Tell of Today’s Conflicts and Reality Profitability through Simplicity, Pharmaceutical Processing November 15, 2012
  174. Malhotra, Girish: The Op-Ed: Some Indian Drugmakers Need A Fix, January 9, 2013
  175. Malhotra, Girish: Can Falsified Medicine and Other Directives Backfire? Profitability through Simplicity, Pharmaceutical Processing January 31, 2013
  176. Malhotra, Girish: The Secret Life of APIs February 26, 2013
  177. Malhotra, Girish: The Secret Life of APIs:The Importance of Sociochemicology April 4, 2013
  178. Malhotra, Girish: Sociochemicalogy, April 9, 2013
  179. Malhotra, Girish: Lost in Translation? – Can QbD Translate to Jobs in the Pharmaceutical Industry? Pharmaceutical Processing April 17, 2013
  180. Malhotra, Girish: Product Volume & API Process Optimization, May 2, 2013
  181. Malhotra, Girish: Improving APIs & Formulation: Are You Harnessing the Power of Liquids? May 14, 2013
  182. Chemical & Engineering News Volume 91 Issue 21 pp. 30-31 May 27, 2013
  183. Malhotra, Girish: Is it Time to Revamp cGMPs? May 29, 2013
  184. Malhotra, Girish: QbD:Its Value, Impact and Economics, Pharma-QbD Forum, June 12-14, The LaLit, Mumbai India
  185. Malhotra, Girish: The Art of API Simplification and QbD based Manufacturing, Pharma-QbD Forum, June 12-14, The LaLit, Mumbai India
  186. Malhotra, Girish: QbD on the Menu at CPhI Mumbai: Industry Savings of $200 Billion Possible, June 19,
  187. Malhotra, Girish: Can Clinton/Gates Save Pharma? June 24, 2013
  188. Malhotra, Girish: Letter to Indian Pharma CEOs: Have You Lost Your Chance to Innovate? July 26, 2013
  189. Malhotra, Girish: Increasing Profits by Reaching Pharma’s Silent Majority, August 5, 2013
  190. Malhotra, Girish:Shift to continuous process from batch and reap the benefits, Chemical Industry Digest, Vol.XXVI 8, August, 2013, pg. 7
  191. Malhotra, Girish: Conflicts and opportunities in the Life of APIs, Chimica Oggi-Chemistry Today Vol. 31 (4) July/August 2013 pgs. 10-13
  192. Malhotra, Girish: Imagine… a Process-Centered Pharma September 11, 2013
  193. Malhotra, Girish: Millions? Billions? Millions? Billions? A Matter of Perspective  September 21, 2013
  194. Malhotra, Girish: CPhI Pharma Evolution Annual Industry Report part 2, pgs 22-25 October 2013
  195. Malhotra, Girish:The Nail That Sticks Out Could Change the World: When Culture Stifles Innovation, November 14, 2013
  196. Malhotra, Girish: Break the Rag Layer, Chemical Processing Process Puzzler, November 2013, Page 50
  197. Malhotra, Girish: Indian Producers have to Consider a Process Centric Model, page 58, 61, November 2013
  198. Malhotra, Girish:Could the Google Books Decision Set a Precedent for Global Pharma Patents? December 10, 2013
  199. Malhotra, Girish: Revamp the Process, Chemical Processing, Process Puzzler, December 2013 Page 32
  200. Malhotra, Girish:Can Emerging Pharma’s Leadership Move On to the Next Stage? December 18, 2013
  201. Malhotra, Girish: Reading the Tea Leaves: Predictions for Pharma’s Future, January 15, 2014
  202. Malhotra, Girish:Will Pharma’s Global Customers Redefine Maslow’s Hierarchy of Needs? January 27, 2014
  203. Malhotra, Girish: What Do The Recent Ranbaxy Citations Teach Us? Profitability through Simplicity, February 4, 2014
  204. Malhotra, Girish:Safety and Safe Practices in Chemical Manufacturing, March 17, 2014 Presented at Cleveland State University Senior Class
  205. Malhotra, Girish: Ranbaxy: Lessons and Opportunities, Contract Pharma, April 9, 2014, Contract Pharma, May, 2014 pg 28-29
  206. Malhotra, Girish: Sun Pharma’s Exotic Challenge: How Real?, Profitability through Simplicity, April 23, 2014
  207. Malhotra, Girish: API Manufacturing’s Stuck in the Mud. Pharmaceutical Manufacturing, May 2014 pg 42
  208. Malhotra, Girish:Toward a Process-Centered Pharma, Contract Pharma, Vol.16, 5, Pg 46-48, June 2014
  209. Malhotra, Girish: INJECT THE WAX AT THE PUMP, Chemical Processing, July 10, 2014
  210. Malhotra, Girish: Why Fitting a Square Plug in a Round hole is Profitable for Pharma and Most Likely Will Stay? Profitability through Simplicity, Pharmaceutical Processing, August 1, 2014
  211. Malhotra, Girish: Landscape Disrupters Are Becoming Part of the Pharma’s Playing Field, Profitability through Simplicity, August 17, 2014
  212. Malhotra, Girish: Are Toyota’s manufacturing practices the right benchmark for the pharma? Chemica Oggi-Chemistry Today, Vol. 32(4), pg. 2-3,July/August 2014
  213. Malhotra, Girish:A Blueprint for Improved Pharma Competitiveness, Contract Pharma, Vol. 16, 7, Pg. 46-49, September 2014
  214. Malhotra, Girish: Is McLaren Going to be Pharma’s “Creative Destructionist”? Profitability through Simplicity, October 14, 2014
  215. Malhotra, Girish: Regulatory Compliance vs. Operational Excellence: What Should Happen First? Profitability through Simplicity, February3, 2015
  216. Malhotra, Girish: Compliance vs. Operational Excellence, Pharmaceutical Manufacturing, pg. 50, March 2015
  217. Malhotra, Girish:Could Pharma’s New Movers and Shakers Make a Difference? Profitability through Simplicity, April 24, 2015
  218. Malhotra, Girish:May Day May Day: Can Someone Help and Lower Drug Prices?Profitability through Simplicity, May 1, 2015
  219. Malhotra, Girish:How to Justify Innovation and QbD in Manufacturing, Pharmaceutical Manufacturing, May 4, 2015 Pg. 35-36
  220. Malhotra, Girish:Continuous Process in Pharmaceutical Manufacturing: Considerations, Nuances and Challenges, Contract Pharma, June 2, 2015
  221. Malhotra, Girish: Can An Alliance Between US Pharmaceutical Benefit Managers (1) and Make in India (2) Lead to Lower Global Drug Prices?, Profitability through Simplicity, June 17, 2015
  222. Malhotra, Girish: Are Software Technologies Going to be Pharma’s Creative Destructionists?, Profitability through Simplicity, July 14, 2015
  223. Malhotra, Girish: Impact of 21CFR 314.70 on The Life of a Pharmaceutical Manufacturing Process, Profitability through Simplicity, August 7, 2015
  224. Malhotra, Girish: Could Software Technologies be the “Creative Destructionist” for Pharmaceuticals and Chemicals?, Profitability through Simplicity, August 31, 2015
  225. Malhotra, Girish: Manufacturing technologies and their part, Chemica Oggi Chemistry- Today, September/October 2015 Vol. 33(5) pg. 28-31
  226. Malhotra, Girish: My perspective for Pharmaceutical Manufacturing Technologies/Processes and Continuous Improvements, CPhI 2015,
  227. Malhotra, Girish: Is Pharma’s Goal to Serve Patients Per Billion or Million? Profitability through Simplicity October 2, 2015
  228. Malhotra, Girish: Mitigate a Manager’s Mayhem: Go Back to Original Design, Chemical Processing, October 2015
  229. Malhotra, Girish: Cleveland State University, Lecture to Two Senior Classes, Social Behavior of Chemicals, October 21, 2015
  230. Malhotra, Girish: Calling for Change, Profitability through Simplicity, November 17, 2015
  231. Malhotra, Girish: Is FDA Rule 21CFR314.70 a Case of “Shackled Freedom” for Pharmaceutical Manufacturing?, Profitability through Simplicity, Pharmaceutical Processing, November 19, 2015
  232. Malhotra, Girish:Who Is/Or Should Be Driving Pharma’s Manufacturing Car: Regulators or the Regulated? Profitability through Simplicity, December 7, 2015
  233. Malhotra, Girish: Pharma’s Landscape’s going to look a lot different in 2026 February 5, 2016
  234. Malhotra, Girish: Continuous Pharmaceutical Processes and Their Demands, Contract Pharma, pg 37-40, April 5, 2016
  235. Malhotra, Girish: Can Senate And House Bills S2615 And HR 4784 [Increasing Competition in Pharmaceuticals Act] Alter the Pharmaceutical Landscape?, Profitability through Simplicity, May 26, 2016
  236. Malhotra, Girish: Pharmaceutical Process:  Batch or Continuous Reality, Myth or Imagination, Contract Pharma: 2016 Contracting and Outsourcing Conference, New Brunswick, September 23, 2016
  237. Malhotra, Girish: Manufactuirng Processes Require Financial Justification, CPhI, September 26, 2016 pgs12-14
  238. Malhotra, Girish: Manufacturing Processes Require Financial Justification, Contract Pharma, September 27, 2016
  239. Malhotra, Girish: Financial Justification in Pharma, Pharmaceutical Manufacturing, Volume 15, Issue 9, November 4, 2016
  240. Malhotra, Girish: Process Innovations: Who Should Lead & Their Impact?, Contract Pharma, November 9, 2016 Vol. 18 No. 9, pg 69-71
  241. Malhotra, Girish: Industry 4.0 (Digitization): Its Benefits to Pharma and Other Chemical Industries, Profitability through Simplicity, November 11, 2016
  242. Malhotra, Girish: Opportunity to showcase excellence and drive forward industry standards: the CPhI Awards, Chemica Oggi-Chemistry Today, Vol 34(6), November/December 2016, pgs 64-65
  243. Malhotra, Girish: Develop A Dialog, Chemical Processing, December 2016, Vol. 78, Issue 12
  244. Malhotra, Girish: Can Uniform Safety, Health and Effluent and Manufacturing Standards Create Process Technology Innovation and Competition in Pharmaceuticals? Profitability through Simplicity, January 10, 2017


MBA Program; Xavier University – Cincinnati, OH; 1977-1979
M.S. ; Chemical Engineering; Clarkson University – Potsdam, NY; 1968
Graduate Diploma; Petroleum Refining; Indian Institute of Petroleum – India; 1966
B.S.; Chemical Engineering; Harcourt Butler Technological Institute – India; 1965
Seminars in: Drug delivery systems, radiation curing, pressure sensitive and release technologies, technology management, digital imaging, crystallization.


Improved operating efficiency of a waste treatment plant by 40% without any investment.
Established a joint venture in India to produce and market Waterless Hand Cleaner.
Established global leadership by developing strategic alliances in digital imaging for Morgan Adhesives Co. at 50% gross margin.
Selected and executed an exclusive global agreement with a supplier to lower costs by 20% /year for Morgan Adhesives Co.
Improved product development process to reduce time to market to three months from nine months for self-adhesive product line.
Maximized global patent protection and coverage to achieve exclusive relationship with customers.
Coordinated development of proprietary raw material with other operating companies.
Managed worldwide technology transfer for self-adhesives.
Tracked and evaluated self-adhesive and digital imaging technologies and recommended business opportunities.
Conceptualized and directed development of a single ply battery label with “ON” battery tester.
Achieved $700,000 paint inventory reduction by integrated inventory and sales analysis.
Rationalized and reduced Dutch Boy Brands SKU’s by 14% and identified 30% SKU reduction without loss of any business.
Conceived and commercialized a unique “convenience” home repair package for the retail market.
Conducted due diligence to acquire pilot plant for Sherwin Williams.
Devised decentralization plan for corporate and division research and development efforts.
Tested and implemented equipment resulting in 25% lower re-labeling cost and higher quality paints.
Conceptualized and demonstrated continuous paint manufacturing process producing consistent quality paint leading to raw material consolidation and lower cost.
Conceptualized, developed, tested, and implemented a semi-continuous paint manufacturing process that reduced costs 40%.
Conceptualized and commercialized continuous latex emulsion process producing higher quality, lower cost and lower monomer product compared to batch processes.
Conceived technology for continuous production of emulsion latex, alkyd, polyester, epoxy, and phenolic resins. Developed chemistries and demonstrated process feasibility.
Managed program to recycle obsolete paint to new products and other uses.
Conceptualized and demonstrated semi-continuous manufacturing of solvent based paints.
Managed chemical plant profitability from -3.7% to 7% in two years, by improving productivity, and reducing manufacturing costs and inventories.
Coordinated with Sales and Marketing to increase site revenue by $5 million in one year.
Implemented processing changes to double resin capacity and reduced operating time 40% without any investment.
Reduced manufacturing cost of an antioxidant and saved $3.5 million.
Reduced antioxidant cost by 30% and doubled capacity without any capital investment.
Directed start-up of food grade antioxidant plant.
Met 110% of manufacturing plan while operating at 85% of budget.
Established quality circles; increased capacity without capital investment and saved over $500,000 per year.
Increased chemical intermediate capacity by 75% with a $40,000 investment, adding $1 million per year to factory profit.
Introduced operating procedures to improve corrosion inhibitor product quality resulting in doubling business.
Directed and provided support to Manufacturing to reduce cost, improve quality and capacity increase to meet increased market needs.
Directed development and implementation of continuous esterification process for methyl anthranilate.
Developed continuous process for dyes and pigments resulting in 15-25% profitability improvement and process effluent reduction.
Developed and commercialized new custom chemicals.
Developed hydrocarbon emission standards for State of Illinois.
Developed Air pollution permit system for State of Illinois.
Designed ethylene plants for Exxon.
Conceptualized ethylene production from petroleum residue.


Continuous and batch Diazotization, Esterification, Hydrogenation, Amination, Chlorination, Chloro-sulfonation, Nitration, Alkylation, Friedel Crafts Reaction, Chemical Reduction, Carboxylation, Sulfonation, Hydrolysis, Continuous and batch Emulsion polymerization etc.